Hypertension affects nearly half of all Americans and more than one billion people worldwide. Hypertension, or high blood pressure, affects nearly half of all Americans and more than one billion ...
According the World Health Organization, the number of adults with hypertension doubled between 1990 and 2019 from 650 million to 1.3 billion. When left uncontrolled, hypertension can lead to serious ...
PALO ALTO, Calif., July 2, 2018 /PRNewswire/ -- ReCor Medical announced today that the US Food & Drug Administration approved the Company's new pivotal study of the Paradise Ultrasound Denervation ...
RONKONKOMA, N.Y., ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ...
ReCor Medical has announced that the first patients, 292 total, have been enrolled in its Radiance-HTN study of its Paradise renal denervation device designed to treat hypertension. The study, blind ...
Results presented at EuroPCR 2022 show notable reduction of blood pressure in patients on and off medications at six months PALO ALTO, Calif.--(BUSINESS WIRE)--ReCor Medical, Inc. (“ReCor”) and Otsuka ...
FRANKFURT, Germany—ReCor Medical, an emerging medical device company, announced today that its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation has ...
Palo Alto, CA, May 15, 2026 (GLOBE NEWSWIRE) -- In recognition of World Hypertension Day 2026, Recor Medical, Inc. (“Recor”), a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., joins the ...
May 17 is World Hypertension Day, a global initiative to highlight the importance of monitoring blood pressure and provide education about this devastating chronic disease. Recor Medical – the pioneer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results